Perseus Biomics

A paradigm shift in metagenomics

Leuven, Belgium · Founded 2016 · $2.5M raised

Headquarters
Leuven
Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$2.5M
Last Round
$2.5M GrantFeb 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Perseus Biomics is a Leuven, Belgium-based biotechnology company that developed DynaMAP, a metagenomic technology platform delivering high-resolution, strain-level microbiome analysis. Spun out of a joint KU Leuven and EPFL research project originally backed by an ERC Advanced Grant, the company offers both an in-house MetaMAP device and a full-service microbiome profiling service for R&D, nutrition, precision-medicine, and biotics/food/therapeutics customers needing strain identity verification and contamination screening.

Summary

Perseus Biomics is a Biotech company based in Leuven, Belgium, founded in 2016. It has raised $2.5M in total across 2 rounds, most recently a $2.5M Grant round in Feb 2024. Investors include European Innovation Council Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantFeb 2024
$2.5M

Sign up to see all 2 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Perseus Biomics on Indexed.vc
<a href="https://indexed.vc/companies/perseus-biomics"><img src="https://indexed.vc/api/badge/company/perseus-biomics" alt="Perseus Biomics on Indexed.vc" width="260" height="76" /></a>